HUP0400946A2 - (S)-2-etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és egy gyógyhatású biguanidot tartalmazó gyógyszerkombináció - Google Patents

(S)-2-etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és egy gyógyhatású biguanidot tartalmazó gyógyszerkombináció

Info

Publication number
HUP0400946A2
HUP0400946A2 HU0400946A HUP0400946A HUP0400946A2 HU P0400946 A2 HUP0400946 A2 HU P0400946A2 HU 0400946 A HU0400946 A HU 0400946A HU P0400946 A HUP0400946 A HU P0400946A HU P0400946 A2 HUP0400946 A2 HU P0400946A2
Authority
HU
Hungary
Prior art keywords
ethoxy
phenyl
propanoic acid
tert
pharmaceutical combination
Prior art date
Application number
HU0400946A
Other languages
English (en)
Inventor
Peter Öhman
Original Assignee
Astrazeneca Ab,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, filed Critical Astrazeneca Ab,
Publication of HUP0400946A2 publication Critical patent/HUP0400946A2/hu
Publication of HUP0400946A3 publication Critical patent/HUP0400946A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Abstract

A találmány tárgya gyógyszerkombináció, ami (S)-2-etoxi-3-[4[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat, vagygyógyászatilag alkalmazható sóját vagy a vegyület vagy a sószolvátját, vagy 3-[4-[2-[4-(terc-butoxi-karbonitamino)-fenil]-etoxi]-fenil]-(S)-2etoxi-propánsavat, vagy gyógyászatilag alkalmazható sóját,vagy a vegyület vagy a só szolvátját tartalmazza, egy gyógyhatásúbiguaniddal együtt. Ó
HU0400946A 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug HUP0400946A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101980A SE0101980D0 (sv) 2001-06-01 2001-06-01 Pharmaceutical combination
PCT/SE2002/001038 WO2002096402A1 (en) 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug

Publications (2)

Publication Number Publication Date
HUP0400946A2 true HUP0400946A2 (hu) 2004-08-30
HUP0400946A3 HUP0400946A3 (en) 2007-11-28

Family

ID=20284362

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400946A HUP0400946A3 (en) 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug

Country Status (25)

Country Link
US (1) US20040152771A1 (hu)
EP (2) EP1666034A1 (hu)
JP (1) JP2004532864A (hu)
KR (1) KR20040008202A (hu)
CN (1) CN1535144A (hu)
AT (1) ATE336993T1 (hu)
BR (1) BR0210128A (hu)
CA (1) CA2448643A1 (hu)
CO (1) CO5540375A2 (hu)
CZ (1) CZ20033234A3 (hu)
DE (1) DE60214185T2 (hu)
EE (1) EE200300584A (hu)
ES (1) ES2269686T3 (hu)
HK (1) HK1062813A1 (hu)
HU (1) HUP0400946A3 (hu)
IL (1) IL159033A0 (hu)
IS (1) IS7058A (hu)
MX (1) MXPA03011005A (hu)
NO (1) NO20035237D0 (hu)
PL (1) PL367891A1 (hu)
RU (1) RU2003136154A (hu)
SE (1) SE0101980D0 (hu)
SK (1) SK14702003A3 (hu)
WO (1) WO2002096402A1 (hu)
ZA (1) ZA200309264B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201636015A (zh) * 2013-07-05 2016-10-16 卡地拉保健有限公司 協同性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
ATE266409T1 (de) * 2000-04-13 2004-05-15 Pfizer Prod Inc Synergistische wirkung von glyburide und milrinone

Also Published As

Publication number Publication date
DE60214185D1 (en) 2006-10-05
BR0210128A (pt) 2004-06-08
HK1062813A1 (en) 2004-11-26
HUP0400946A3 (en) 2007-11-28
WO2002096402A1 (en) 2002-12-05
EP1666034A1 (en) 2006-06-07
EE200300584A (et) 2004-02-16
CN1535144A (zh) 2004-10-06
EP1404309B1 (en) 2006-08-23
MXPA03011005A (es) 2004-02-27
SK14702003A3 (sk) 2004-09-08
ES2269686T3 (es) 2007-04-01
NO20035237D0 (no) 2003-11-25
SE0101980D0 (sv) 2001-06-01
EP1404309A1 (en) 2004-04-07
ZA200309264B (en) 2005-02-28
CZ20033234A3 (cs) 2004-12-15
ATE336993T1 (de) 2006-09-15
JP2004532864A (ja) 2004-10-28
US20040152771A1 (en) 2004-08-05
PL367891A1 (en) 2005-03-07
KR20040008202A (ko) 2004-01-28
IS7058A (is) 2003-11-28
DE60214185T2 (de) 2007-07-19
CO5540375A2 (es) 2005-07-29
CA2448643A1 (en) 2002-12-05
IL159033A0 (en) 2004-05-12
RU2003136154A (ru) 2005-02-10

Similar Documents

Publication Publication Date Title
JP2007502806A5 (hu)
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
TR200003543T2 (tr) Yeni 3-aril-2-hidroksipropiyonik asit türevi III.
JP2009501704A5 (hu)
DK1237854T3 (da) Pulveriseret form af (S)-2-ethoxy-3-[4-(2-(4-methan sulfonyloxyphenyl)ethoxy)phenyl]propanonsyre
DK1237855T3 (da) Krystallinsk form af (S)-2-ethoxy-3-[4-(2-(4-methansulfonyloxyphenyl)ethoxy)phenyl]propansyre
WO2007066163A3 (en) Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates
JP2003515583A5 (hu)
HUP0400946A2 (hu) (S)-2-etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és egy gyógyhatású biguanidot tartalmazó gyógyszerkombináció
HUP0400964A2 (hu) (S)-2-Etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és inzulint tartalmazó gyógyszer-kombináció
HUP0401613A2 (hu) (S)-2-Etoxi-3-[4-[2-[4-(metánszulfonil-oxi)-fenil]-etoxi]-fenil]-propánsavat vagy 3-[4-[2-[4-(terc-butoxi-karbonil-amino)-fenil]-etoxi]-fenil]-(S)-2-etoxi-propánsavat és egy szulfonil-karbamidot tartalmazó gyógyszer-kombináció
IS8224A (is) Amínsölt (-)-2-{[2-(4-hýdroxýfenýl)etýl]-þíó}-3-[4-(2-{4-[(metýlsúlfónýl)oxý]fenoxý}etýl)fenýl]própansýru og notkun þeirra í læknisfræði
IL172376A0 (en) Process for the preparation of racemic 2{[2-(4- hydroxyphenyl)ethyl]thio}-3-[4-(2-{4- [(methylsulphonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
UA92770C2 (ru) СПОСОБ ПОЛУЧЕНИЯ {2-[4-(а-ФЕНИЛ-п-ХЛОРБЕНЗИЛ)-ПИПЕРАЗИН-1-ИЛ]-ЭТОКСИ}-УКСУСНОЙ КИСЛОТЫ N,N-ДИМЕТИЛАМИДА ИЛИ ЕГО ЭНАНТИОМЕРОВ
UY28371A1 (es) Agentes terapéuticos
CO5590908A2 (es) Derivados de acido 3-fenil-2-arilalquiltiopropionico como antagonistas selectivos de ppar-alfa
USD517208S1 (en) Hygienic cleaning tool for ears
RS52014B (sr) Nova so benzoilgvanidina
AU2001290743A1 (en) Solid salt forms of n-(2-(4-(2-(1-methylethoxy)phenyl)-1-piperazinyl)ethyl)-2-oxo-1-piperidineacetamide
TH26872A (th) สารประกอบต่าง ๆ ชนิดใหม่
TH77460B (th) สารเชิงการบำบัด
EA200501693A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ОСОБО ЧИСТОГО ФУМАРАТА рац-1-{4-[2-ГИДРОКСИ-3-(5-ХИНОЛИЛОКСИ)ПРОПИЛ]ПИПЕРАЗИН-1-ИЛ}-2,2-ДИФЕНИЛЭТАН-1-ОНА И ОСОБО ЧИСТЫЙ ФУМАРАТ рац-1-{4-[2-ГИДРОКСИ-3-(5-ХИНОЛИЛОКСИ)ПРОПИЛ]ПИПЕРАЗИН-1-ИЛ}-2,2-ДИФЕНИЛЭТАН-1-ОНА

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees